2485020-60-6

2485020-60-6 structure
2485020-60-6 structure
  • Name: Elarekibep
  • Chemical Name: Elarekibep
  • CAS Number: 2485020-60-6
  • Molecular Formula:
  • Molecular Weight:
  • Catalog: Research Areas Inflammation/Immunology
  • Create Date: 2023-04-18 16:50:07
  • Modify Date: 2025-08-26 17:31:59
  • Elarekibep (PRS-060) (AZD1402) is a high affinity, slowly dissociating, long-acting full antagonist of IL-4Ra. Elarekibep can be used for the research of T2 endotype asthma[1].

Name Elarekibep
Description Elarekibep (PRS-060) (AZD1402) is a high affinity, slowly dissociating, long-acting full antagonist of IL-4Ra. Elarekibep can be used for the research of T2 endotype asthma[1].
Related Catalog
In Vitro Elarekibep (PRS-060) (0-10 µM) 抑制 IL-4 或 IL-13 诱导的 STAT-6 磷酸化,IC50 值分别为 0.12 nM 和 0.10 nM[ 1]. PRS-060 (0-10 µM) 抑制 hIL-4 或 hIL-13 诱导的 TF-1 细胞增殖,IC50 值分别为 0.87 nM 和 0.92 nM[1]< /sup>. PRS-060 (0-10 µM) 抑制 hIL-13 诱导的人上皮细胞粘液转分化,IC50 值为 0.3 nM[1]。
In Vivo PRS-060(气管内滴注;2、10、50 µg)抑制人源化小鼠肺中 IL-13 诱导的 eotaxin-1 表达和卵清蛋白诱导的急性过敏性炎症[1]。 Animal Model: Triple-humanized mouse model[1] Dosage: 2, 10, 50 µg/mouse Administration: Intratracheal instillation (i.t) Result: Strongly suppressed acute allergic inflammation indices in triple humanized mice.
References

[1]. Gabriele Matschiner, et al. Elarekibep (PRS-060/AZD1402): a new class of inhaled Anticalin medicine targeting IL-4Ra for T2 endotype asthma. J Allergy Clin Immunol. 2022 Dec 30;S0091-6749(22)02588-X.  

No Any Chemical & Physical Properties
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.